Literature DB >> 34654591

DNA methylation in lung cancer patients: Opening a "window of life" under precision medicine.

Runzhang Liang1, Xiaosong Li2, Weiquan Li3, Xiao Zhu4, Chen Li5.   

Abstract

DNA methylation is a work of adding a methyl group to the 5th carbon atom of cytosine in DNA sequence under the catalysis of DNA methyltransferase (DNMT) to produce 5-methyl cytosine. Some current studies have elucidated the mechanism of lung cancer occurrence and causes of lung cancer progression and metastasis from the perspective of DNA methylation. Moreover, many studies have shown that smoking can change the methylation status of some gene loci, leading to the occurrence of lung cancer, especially central lung cancer. This review mainly introduces the role of DNA methylation in the pathogenesis, early diagnosis and screening, progression and metastasis, treatment, and prognosis of lung cancer, as well as the latest progress. We point out that methylation markers, sample tests, and methylation detection limit the clinical application of DNA methylation. If the liquid biopsy is to become the main force in lung cancer diagnosis, it must make efficient use of limited samples and improve the sensitivity and specificity of the tests. In addition, we also put forward our views on the future development direction of DNA methylation.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Biomarker; DNA methylation; Liquid biopsy; Lung cancer; Prognosis; Treatment

Mesh:

Substances:

Year:  2021        PMID: 34654591     DOI: 10.1016/j.biopha.2021.112202

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  16 in total

1.  Deciphering the Role of Shugoshin-Like Protein 1 in Lung Adenocarcinoma: A Comprehensive Analysis and In Vitro Study.

Authors:  Yixiao Yuan; Juan Wang; Dahang Zhang; Lin Tang; Lincan Duan; Xiulin Jiang
Journal:  Front Oncol       Date:  2022-05-03       Impact factor: 5.738

2.  Editorial: Epigenetics in Cancer: Mechanisms and Drug Development.

Authors:  Huiqing Yuan; Yongmei Huang; Susu Tao; Biaoru Li; Zhenhua Xu; Yi Qi; Binhua Wu; Hui Luo; Xiao Zhu
Journal:  Front Genet       Date:  2022-06-28       Impact factor: 4.772

3.  Immune-Related miRNA-195-5p Inhibits the Progression of Lung Adenocarcinoma by Targeting Polypyrimidine Tract-Binding Protein 1.

Authors:  Lincan Duan; Juan Wang; Dahang Zhang; Yixiao Yuan; Lin Tang; Yongchun Zhou; Xiulin Jiang
Journal:  Front Oncol       Date:  2022-05-05       Impact factor: 5.738

4.  Long Non-Coding RNA AP000695.2 Acts as a Novel Prognostic Biomarker and Regulates the Cell Growth and Migration of Lung Adenocarcinoma.

Authors:  Chunyan Wang; Jishu Guo; Rongyan Jiang; Chenyang Wang; Chenglong Pan; Zhi Nie; Xiulin Jiang
Journal:  Front Mol Biosci       Date:  2022-05-24

5.  FOXM1/lncRNA TYMSOS/miR-214-3p-Mediated High Expression of NCAPG Correlates With Poor Prognosis and Cell Proliferation in Non-Small Cell Lung Carcinoma.

Authors:  Yixiao Yuan; Xiulin Jiang; Lin Tang; Juan Wang; Dahang Zhang; William C Cho; Lincan Duan
Journal:  Front Mol Biosci       Date:  2022-02-08

6.  MicroRNA-125b-5p Correlates With Prognosis and Lung Adenocarcinoma Progression.

Authors:  Lin Tang; Yixiao Yuan; Haoqing Zhai; Juan Wang; Dahang Zhang; Huasu Liang; Yulin Shi; Lincan Duan; Xiulin Jiang
Journal:  Front Mol Biosci       Date:  2022-02-03

Review 7.  DNA Methylation in Lung Cancer: Mechanisms and Associations with Histological Subtypes, Molecular Alterations, and Major Epidemiological Factors.

Authors:  Phuc H Hoang; Maria Teresa Landi
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

8.  Identification and Validation Prognostic Impact of MiRNA-30a-5p in Lung Adenocarcinoma.

Authors:  Xiulin Jiang; Yixiao Yuan; Lin Tang; Juan Wang; Dahang Zhang; William C Cho; Lincan Duan
Journal:  Front Oncol       Date:  2022-01-20       Impact factor: 6.244

9.  LncRNA-AC068228.1 Is a Novel Prognostic Biomarker That Promotes Malignant Phenotypes in Lung Adenocarcinoma.

Authors:  Xiulin Jiang; Min Chen; Junyi Du; Hong Bi; Xiang Guo; Chao Yang; Xu He; Zhixian Jin
Journal:  Front Oncol       Date:  2022-02-23       Impact factor: 6.244

10.  NcRNA-Mediated High Expression of HMMR as a Prognostic Biomarker Correlated With Cell Proliferation and Cell Migration in Lung Adenocarcinoma.

Authors:  Xiulin Jiang; Lin Tang; Yixiao Yuan; Juan Wang; Dahang Zhang; Kebao Qian; William C Cho; Lincan Duan
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.